Smart Inhaler for Teens with Intellectual Disabilities and Asthma
Part of Brain & nervous system, Immune system & allergy, Lungs & breathing, Mental health clinical trials.
This study tests a 'smart' inhaler that tracks when and how your child uses their asthma medicine. The goal is to help teens with intellectual or developmental disabilities manage asthma better at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 10 to 17 years old.
- Your child must have a mild-to-moderate intellectual disability or a developmental disability (like autism).
- Your child must have moderate-to-severe asthma (not mild asthma).
- Your child must use one of these inhalers: Ventolin, ProAir, Advair, Flovent, Xopenex, Symbicort, Atrovent, Proventil, Alvesco, Dulera, or Asmanex HFA.
- You and your child must be willing to follow study steps and answer questions about your child's health.
- Your child should not be in any other study that uses a smart inhaler.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart inhaler and a phone app to help teenagers with mild-to-moderate intellectual or developmental disabilities manage their asthma at home. It aims to see if this technology improves asthma control and makes it easier for families to track medication use.
This study tests whether a sensor that tracks inhaler use can help children ages 4–17 with persistent or uncontrolled asthma. It aims to make managing asthma at home easier for caregivers.
This study tests a new way to help teenagers with moderate to severe asthma manage their condition better. Researchers will work with you and your doctor to create a personalized asthma action plan and see if it helps you control your symptoms and reduce flare-ups.
This trial is testing a new program called SMART@Home that helps teens manage their long-term health conditions using a smartphone app. It aims to see if this approach is practical and helpful for teens with conditions like asthma.
This study tests how well a digital device that tracks your inhaler use works for people with lung conditions like COPD or asthma. It's a small initial study to see if this approach is helpful.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Hear when a new Asthma in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.